CSIMarket
 
Paragon 28 inc   (NYSE: FNA)
 

Paragon 28 Inc's Suppliers Performance

FNA's Supply Chain




 
FNA Costs vs Sales of Suppliers Growth Paragon 28 Inc's cost of sales deteriorated by -13.93 % year on year, sequentially cost of sales grew by 25 % in Q4.

More on FNA Suppliers



Paragon 28 Inc's cost of sales deteriorated by -13.93 % year on year, sequentially cost of sales grew by 25 % in Q4.

More on FNA Suppliers




Paragon 28 Inc's Comment on Supply Chain


The Human Tissue Act 2004 and the Human Tissue (Scotland) Act 2006 regulate the removal, storage, and use of human tissue in the UK. The Human Tissue (Quality and Safety for Human Application) Regulations 2007, as amended, require establishments involved in procurement, testing, processing, export, and distribution of human tissues and cells to hold appropriate licenses from the Human Tissue Authority (HTA). Third-party agreements may authorize these activities if they comply with HTA standards. Licensed establishments must appoint a designated individual responsible for ensuring compliance and reporting serious adverse events or reactions within 24 hours. Importers and exporters must demonstrate that tissues and cells meet required quality and safety standards. Since July 1, 2021, establishments in Great Britain importing or exporting human tissues or cells to or from European Economic Area countries must obtain an HTA license. Licensing requirements for transfers to Northern Ireland remain unchanged following Brexit. Additionally, suppliers' activities related to sourcing and processing animal tissues and derivatives must be audited to eliminate or inactivate pathogens.

Paragon 28 Inc's Comment on Supply Chain


The Human Tissue Act 2004 and the Human Tissue (Scotland) Act 2006 regulate the removal, storage, and use of human tissue in the UK. The Human Tissue (Quality and Safety for Human Application) Regulations 2007, as amended, require establishments involved in procurement, testing, processing, export, and distribution of human tissues and cells to hold appropriate licenses from the Human Tissue Authority (HTA). Third-party agreements may authorize these activities if they comply with HTA standards. Licensed establishments must appoint a designated individual responsible for ensuring compliance and reporting serious adverse events or reactions within 24 hours. Importers and exporters must demonstrate that tissues and cells meet required quality and safety standards. Since July 1, 2021, establishments in Great Britain importing or exporting human tissues or cells to or from European Economic Area countries must obtain an HTA license. Licensing requirements for transfers to Northern Ireland remain unchanged following Brexit. Additionally, suppliers' activities related to sourcing and processing animal tissues and derivatives must be audited to eliminate or inactivate pathogens.







FNA's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Paragon 28 inc 1,082.21 255.49 -54.64 144
SUBTOTAL 0.00 0.00 0.00 -


Sources: Paragon 28 inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Paragon 28 inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.